ScreenIT
The Automated Screening Working Groups is a group of software engineers and biologists passionate about improving scientific manuscripts on a large scale. Our members have created tools that check for common problems in scientific manuscripts, including information needed to improve transparency and reproducibility. We have combined our tools into a single pipeline, called ScreenIT. We're currently using our tools to screen COVID preprints.
Latest preprint reviews
-
Variation in COVID-19 booster uptake in England: An ecological study
This article has 1 author:Reviewed by ScreenIT
-
The Age-Related Probability of Dying from COVID-19 among Those Infected: A Relative Survival Analysis
This article has 4 authors:Reviewed by ScreenIT
-
Blood Transcriptomes of SARS-CoV-2–Infected Kidney Transplant Recipients Associated with Immune Insufficiency Proportionate to Severity
This article has 21 authors:Reviewed by ScreenIT
-
Psychological distress and work and social adjustment in the COVID-19 pandemic: a cross-Country analysis
This article has 3 authors:Reviewed by ScreenIT
-
In silico analysis of predicted differential MHC binding and CD8+ T-cell immune escape of SARS-CoV-2 B.1.1.529 variant mutant epitopes
This article has 7 authors:Reviewed by ScreenIT
-
A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants
This article has 41 authors:Reviewed by ScreenIT
-
High Frequencies of PD-1 + TIM3 + TIGIT + CTLA4 + Functionally Exhausted SARS-CoV-2-Specific CD4 + and CD8 + T Cells Associated with Severe Disease in Critically ill COVID-19 Patients
This article has 18 authors:Reviewed by ScreenIT
-
Analysis of receptors responsible for the dysfunction of the human immune system by different viral infections
This article has 3 authors:Reviewed by ScreenIT
-
N Gene Target Failure (NGTF) for detection of Omicron: a way out for the ‘stealth’ too?
This article has 27 authors:Reviewed by ScreenIT
-
An intranasal lentiviral booster broadens immune recognition of SARS-CoV-2 variants and reinforces the waning mRNA vaccine-induced immunity that it targets to lung mucosa
This article has 18 authors:Reviewed by ScreenIT